$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
帕比司他:治疗复发性多发性骨髓瘤的首个HDAC抑制剂
2025-10-19 11:44:20
Check Details
多发性骨髓瘤:疼痛程度影响生活质量
2025-10-19 11:44:20
Check Details
冒烟型多发性骨髓瘤是什么?为什么叫冒烟型?
2025-10-19 11:44:20
Check Details
伊沙佐米Ninlaro的用药禁忌是什么?长期用会耐药吗
2025-10-19 11:44:20
Check Details
泊马度胺治疗多发性骨髓瘤的功效与作用!
2025-10-19 11:44:20
Check Details
泊马度胺效果怎么样?泊马度胺和来那度胺的区别是什么?
2025-10-19 11:44:20
Check Details
泊马度胺可以用医保购买吗?副作用和注意事项是什么?
2025-10-19 11:44:20
Check Details
马法兰的适应症和副作用是什么?效果好吗?
2025-10-19 11:44:20
Check Details
多发性骨髓瘤患者选择服用来那度胺能活多久?有什么副作用?
2025-10-19 11:44:20
Check Details
卡非佐米多久一个疗程?长期用卡非佐米治疗会耐药吗
2025-10-19 11:44:20
Check Details
泊马度胺现在能够从北京购买到吗?
2025-10-19 11:44:20
Check Details
来那度胺是化疗药吗,是饭前吃还是饭后吃?
2025-10-19 11:44:20
Check Details
1
2
...
1164
1165
1166
1167
1168
1169
1170
...
4162
4163
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selpercatinib Traditional Approval for RET Fusion Solid Tumors: Weight-Based Adults, BSA-Based Pediatrics, Monitor Liver, BP, QT
2
Atezolizumab Plus mFOLFOX as Adjuvant Therapy for Stage III dMMR Colon Cancer: ATOMIC DFS HR 0.50
3
Tucatinib Plus Trastuzumab and Pertuzumab Maintenance in HER2-Positive Advanced Breast Cancer: HER2CLIMB-05 Median PFS 24.9 Months
4
Zenocutuzumab (Bizengri) for NRG1 Fusion Solid Tumors: HER2×HER3 Bispecific, 750mg Q2W, NSCLC/Pancreas/Cholangiocarcinoma
5
Pemigatinib for FGFR2 Cholangiocarcinoma and FGFR1 Hematologic Use: First-Line Data, 21-Day Dosing, Phosphate and Ocular Management
6
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
7
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
8
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
9
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
10
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
11
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
12
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance